Using rapamycin, a first-generation mTOR inhibitor, we have demonstrated the aggravation of cerebral ischemia at 2 h of reperfusion after 1 h of middle cerebral artery occlusion (MCAO) (Chi et al., 2016a). This evidence concerns the gene MTOR and brain ischemia.